Significance of human striatal D-neurons: Implications in neuropsychiatric functions

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 3, 2004, Pages 429-434

  Ikemoto, Keiko ^a  

^a National Hospital Organization Hanamaki Hospital   (Japan)

Author keywords

AADC; Aromatic L amino acid decarboxylase; D neuron; DA; DDC; Dopa decarboxylase; Dopamine; GTP; Guanosine triphosphate; L dopa; NA; Noradrenaline; Nucleus accumbens; PEA; PET; Phenylethylamine; Striatum

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; LEVODOPA; NORADRENALIN; THREO 3,4 DIHYDROXYPHENYLSERINE;

AUTOPSY; CLINICAL TRIAL; ENZYME SYNTHESIS; HUMAN; NEUROPSYCHIATRY; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PATHOGENESIS; PLURIPOTENT STEM CELL; REVIEW; SCHIZOPHRENIA;

ANIMALS; ANTIPARKINSON AGENTS; DOPA DECARBOXYLASE; HUMANS; LEVODOPA; LIMBIC SYSTEM; MENTAL DISORDERS; NEOSTRIATUM; NERVOUS SYSTEM DISEASES; NEURONS;

EID: 1842828873     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2003.11.017     Document Type: Review

References (57)

1. Anderson A.K., Sobel N. Dissociating intensity from valence as sensory inputs to emotion. Neuron. 39:2003;581-583.
2. Arai R., Karasawa N., Geffard M., Nagatsu I. L-dopa is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study. Neurosci. Lett. 195:1995;195-198.
3. Bankiewicz K.S. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp. Neurol. 164:2000;2-14.
4. Bankiewicz K.S., Pivirotto P., Sanchez-Pernaute R., Herscovitch P., Carson R., Cunningham J., Eckelman W. Adeno-associated viral vector (AAV)-mediated AADC gene delivery results in persistent gene expression and induces functional recovery in MPTP-treated monkeys. The 9th International Catecholamine Symposium. 2001;49. Abstracts.
5. Betarbet R., Turner R., Chockkan V., DeLong M.R., Allers K.A., Walters J., Levey A.I., Greenamyre J.T. Dopaminergic neurons intrinsic to the primate striatum. J. Neurosci. 17:1997;6761-6768.
6. Buckland P.R., Spurlock G., McGuffin P. Amphetamine and vigabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels. Mol. Brain Res. 35:1996;69-76.
7. Buckland P.R., Marshall R., Watkins P., McGuffin P. Does phenylethylamine have a role in schizophrenia?: LSD and PCP up-regulate aromatic L-amino acid decarboxylase mRNA levels. Mol. Brain Res. 49:1997;266-270.
8. Chana G., Landau S., Beasley C., Everall I.P., Cotter D. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol. Psychiatry. 53:2003;1086-1098.
9. Chung C., Tallerico T., Seeman P. Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene. Synapse. 50:2003;29-34.
10. Danielsen E.H., Smith D., Hermansen F., Gjedde A., Cumming P. Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo. Synapse. 41:2001;172-175.
11. Danos P., Baumann B., Kramer A., Bernstein H.G., Stauch R., Krell D., Falkai P., Bogerts B. Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophr. Res. 60:2003;141-155.
12. Delamillieure P., Constans J.M., Fernandez J., Brazo P., Benali K., Courtheoux P., Thibaut F., Petit M., Dollfus S. Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex. Schizophr. Bull. 28:2002;329-339.
13. De La Torre J.C. Catecholamines in the human diencephalons: a histochemical fluorescence study. Acta Neuropathol. 21:1972;165-168.
14. Goshima Y., Miyamae T., Nakamura S., Miki K., Kosaka K., Misu Y. Ventral tegmental injection of nicotine induces locomotor activity and L-DOPA release from nucleus accumbens. Eur. J. Pharmacol. 309:1996;229-233.
15. Hamid E.H., Hyde T.M., Egan M.F., Wolf S.S., Herman M.M., Nemeroff C.B., Kleinman J.E. Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders. Biol. Psychiatry. 51:2002;795-800.
16. Hefti F., Melamed E., Wurtman R.J. The site of dopamine formation in rat striatum after L-dopa administration. J. Pharmacol. Exp. Ther. 217:1981;189-197.
17. Hornykiewicz O. The mechanism of action of L-dopa in Parkinson's disease. Life Sci. 15:1974;1249-1259.
18. Ikemoto K., Kitahama K., Jouvet A., Arai R., Nishimura A., Nishi K., Nagatsu I. Demonstration of L-dopa decarboxylating neurons specific to human striatum. Neurosci. Lett. 232:1997;111-114.
19. Ikemoto K., Nagatsu I., Jouvet A., Nishimura A., Nishi K., Maeda T., Arai R. A dopamine-synthesizing cell group demonstrated in the human basal forebrain by dual labeling immunohistochemical technique of tyrosine hydroxylase and aromatic L-amino acid decarboxylase. Neurosci. Lett. 243:1998;129-132.
20. Ikemoto K., Nagatsu I., Nishimura A., Nishi K., Arai R. Do all of the human midbrain tyrosine hydroxylase neurons synthesize dopamine? Brain Res. 805:1998;255-258.
21. Ikemoto K., Kitahama K., Nishimura A., Jouvet A., Nishi K., Arai R., Jouvet M., Nagatsu I. Tyrosine hydroxylase and aromatic L-amino acid decarboxylase do not coexist in neurons in the human anterior cingulate cortex. Neurosci. Lett. 269:1999;37-40.
22. Ikemoto K., Nishimura A., Okado N., Mikuni M., Nishi K., Nagatsu I. Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration. Brain Res. 853:2000;377-380.
23. Ikemoto K., Nishimura A., Oda T., Nagatsu I., Nishi K. Number of striatal D-neurons is reduced in autopsy brains of schizophrenics. Legal Med. 5:2003;S221-S224.
24. Iritani S., Niizato K., Nawa H., Ikeda K., Emson P.C. Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Prog. Neuropsychopharmacol. Biol. Psychiatry. 27:2003;801-807.
25. Jaeger C.B., Teitelman G., Joh T.H., Albert V.R., Park D.H., Reis D.J. Some neurons of the rat central nervous system contain aromatic-L-amino-acid decarboxylase but not monoamines. Science. 219:1983;1233-1235.
26. Jaeger C.B., Ruggiero D.A., Albert V.R., Joh T.H., Reis D.J. Immunocytochemical localization of aromatic-L-amino acid decarboxylase. Bjorklund A., Hokfelt T. Classical Transmission in the CNS: Part I. Handbook of Chemical Neuroanatomy. vol. 2:1984;387-418 Elsevier, Amsterdam.
27. Jessen F., Scheef L., Germeshausen L., Tawo Y., Kockler M., Kuhn K.U., Maier W., Schild H.H., Heun R. Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. Am. J. Psychiatry. 160:2003;1305-1312.
28. Joyal C.C., Laakso M.P., Tiihonen J., Syvalahti E., Vilkman H., Laakso A., Alakare B., Rakkolainen V., Salokangas R.K., Hietala J. A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia. Biol. Psychiatry. 51:2002;1005-1007.
29. Karasawa N., Nagatsu I., Sakai K., Nagatsu T., Watanabe K., Onozuka M. Immunohistochemical study of catecholaminergic neurons in the senescence-accelerated mouse (SAM-P8) brain. J. Neural Transm. 104:1997;1267-1275.
30. Kaufmann H., Oribe E., Yahr M.D. Treatment of orthostatic hypotension with L-threo-3,4-dihydroxyphenylserine. Narabayashi H., Mizuno Y. Norepinephrine Deficiency and its Treatment with L-threo-DOPS in Parkinson's Disease and Related Disorders. 1993;97-104 The Parthenon Publishing Group, New York.
31. Kitahama K., Ikemoto K., Nagatsu I., Geffard M., Okamura H., Pearson J. Aromatic L-amino acid decarboxylase and tyrosine hydroxylase immunohistochemistry in the adult human hypothalamus. J. Chem. Neuroanat. 16:1998;43-55.
32. Knoll J., Miklya I., Knoll B., Marko R., Racz D. Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain. Life Sci. 58:1996;2101-2114.
33. Komori K., Fujii T., Karasawa N., Yamada K., Nagatsu I. Some neurons of the mouse cortex and caudo-putamen contain aromatic L-amino acid decarboxylase but not monoamines. Acta Histochem. Cytochem. 24:1991;571-577.
34. Komori K., Uesaka S., Yamaoka H., Fujita K., Yamaoka K., Naitoh H., Kuroda M., Karasawa N., Ito T., Kasahara Y., Nagatsu I. Identification of L-DOPA immunoreactivity in some neurons in the human mesencephalic region: a novel DOPA neuron group? Neurosci. Lett. 157:1993;13-16.
35. Koob G.F., Robledo P., Markou A., Caine S.B. The mesolimbic circuit in drug dependence and reward - a role for the extended amygdala? Kalivas P.W., Barnes C.D. Limbic Motor Circuit and Neuropsychiatry. 1993;289-309 CRC Press, Boca Raton.
36. Laurens K.R., Ngan E.T., Bates A.T., Kiehl K.A., Liddle P.F. Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia. Brain. 126:2003;610-622.
37. Lindstrom L.H., Gefvert O., Hagberg G., Lundberg T., Bergstrom M., Hartvig P., Langstrom B. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. Biol. Psychiatry. 46:1999;681-688.
38. Lopez-Real A., Rodriguez-Pallares J., Guerra M.J., Labandeira-Garcia J.L. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models. Brain Res. 969:2003;135-146.
39. Melamed E., Hefti F., Wurtman J. Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in Parkinsonism. Ann. Neurol. 8:1980;558-563.
40. Misu Y., Goshima Y., Ueda H., Okamura H. Neurobiology of L-DOPAergic systems. Prog. Neurobiol. 49:1996;415-454.
41. Mura A., Jackson D., Manley M.S., Young S.J., Groves P.M. Aromatic L-amino acid decarboxylase immunoreactive cells in the striatum: a possible site for the conversion of exogenous L-DOPA to dopamine. Brain Res. 704:1995;51-60.
42. Mura A., Linder J.C., Young S.J., Groves P.M. Striatal cells containing aromatic L-amino acid decarboxylase: an immunohistochemical comparison with other classes of striatal neurons. Neuroscience. 98:2000;501-511.
43. Nagatsu T., Ichinose H., Naoi M. Biochemical basis for the supplementation therapy by L-threo-DOPS. Narabayashi H., Mizuno Y. Norepinephrine Deficiency and its Treatment with L-threo-DOPS in Parkinson's Disease and Related Disorders. 1993;13-24 The Parthenon Publishing Group, New York.
44. Nagatsu I., Ikemoto K., Kitahama K., Nishimura A., Ichinose H., Nagatsu T. Specific localization of the guanosine triphosphate (GTP) cyclohydrolase I-immunoreactivity in the human brain. J. Neural. Transm. 106:1999;607-617.
45. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception: II. Implications for major psychiatric disorders. Biol. Psychiatry. 54:2003;515-528.
46. Porritt M.J., Batchelor P.E., Hughes A.J., Kalnins R., Donnan G.A., Howells D.W. New dopaminergic neurons in Parkinson's disease striatum. Lancet. 356:2000;44-45.
47. Reith J., Benkelfat C., Sherwin A., Yasuhara Y., Kuwabara H., Andermann F., Bachneff S., Cumming P., Diksic M., Dyve S.E.et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc. Natl. Acad. Sci. U. S. A. 91:1994;11651-11654.
48. Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H., Yoshikawa E., Futatsubashi M., Takei N., Mori N. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am. J. Psychiatry. 158:2001;1206-1214.
49. Swoboda K.J., Saul J.P., McKenna C.E., Speller N.B., Hyland K. Aromatic L-amino acid decarboxylase deficiency: overview of clinical features and outcomes. Ann. Neurol. 54(Suppl. 6):2003;S49-S55.
50. Tajima Y., Nakagawa R. Catecholamine precursors improve psychophysical activity. An overview of seven clinical cases. Clin. Drug Investig. 18:1999;329-334.
51. Tashiro Y., Kaneko T., Sugimoto T., Nagatsu I., Kikuchi H., Mizuno N. Striatal neurons with aromatic L-amino acid decarboxylase-like immunoreactivity in the rat. Neurosci. Lett. 100:1989;29-34.
52. Tison F., Mons N., Geffard M., Henry P. The metabolism of exogenous L-dopa in the brain: an immunohistochemical study of its conversion to dopamine in non-catecholaminergic cells of the rat brain. J. Neural. Transm. [P-D Sect]. 3:1991;27-39.
53. Tohgi H., Abe T., Takahashi S. The significance of norepinephrine deficiency in the pathogenesis of freezing phenomena and the effects of L-threo-DOPS. Narabayashi H., Mizuno Y. Norepinephrine Deficiency and its Treatment with L-threo-DOPS in Parkinson's Disease and Related Disorders. 1993;77-86 The Parthenon Publishing Group, New York.
54. Tottordell S., Meredith G. Topographical organization of projections from the entorhinal cortex to the striatum of the rat. Neuroscience. 78:1997;715-729.
55. Willner P., Scheel-Kruger J. The Mesolimbic Dopamine System: From Motivation to Action. 1991;Wiley, Chichester.
56. Yamanashi K., Miyamae T., Misu Y., Goshima Y. Tonic function of nicotinic receptors in stress-induced release of L-DOPA from the nucleus accumbens in freely moving rats. Eur. J. Pharmacol. 424:2001;199-202.
57. Young S.N., Davis B.A., Gauthier S. Precursors and metabolites of phenylethylamine, m- and p-tyramine and tryptamine in human lumbar and cisternal cerebrospinal fluid. J. Neurol. Neurosurg. Psychiatry. 45:1982;639-644.